Hanjo Belz
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment, Palliative Care and End-of-Life Issues, Sarcoma Diagnosis and Treatment, Urinary Bladder and Prostate Research
Most-Cited Works
- → Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study(2019)334 cited
- → Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma after Prior Therapy: Interim Results from the Noninterventional NORA Study(2021)13 cited
- → Urolithiasis bei Kindern – rationelle Diagnostik, Therapie und Metaphylaxe(2008)6 cited
- → Frühe vs. spätere Therapie mit Abirateron plus Prednison bei chemotherapie-naiven, asymptomatischen bis mild symptomatischen Patienten mit metastasiertem CRPC nach Androgendeprivation(2020)3 cited
- → Metastatic Kidney Cancer?(2023)1 cited
- → Prognostic factors for Overall Survival (OS) in patients receiving First-line (1L) Nivolumab plus Ipilimumab (NIVO+IPI) for advanced/metastatic Renal Cell Carcinoma (aRCC) in a real-world setting in Germany(2024)1 cited